In accordance with Rule 13d-1(k)(1) promulgated under the Securities Exchange Act of 1934, as amended, the undersigned hereby agree to the joint filing with each of the Reporting Persons (as such term is defined in the Schedule 13G referred to below) by OCM XAN Holdings PT, LLC, a Delaware corporation, on behalf of each of them of a statement on Schedule 13G (including amendments thereto) with respect to the Common Stock, par value $0.001 per share, of ACRES Therapeutics AP, a Delaware corporation, and that this agreement may be included as an exhibit to such joint filing.